What is Vaso Corp's earnings per share (EPS)?

Vaso Corp (VASO) reported diluted earnings per share of $0.01 for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Vaso Corp Financials

VASO

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE March

This page shows Vaso Corp (VASO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 24/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Vaso Corp has an operating margin of -6.8%, meaning the company retains $-7 of operating profit per $100 of revenue. This below-average margin results in a low score of 7/100, suggesting thin profitability after operating expenses. This is down from 0.3% the prior year.

Growth

Vaso Corp's revenue declined 51.1% year-over-year, from $86.8M to $42.5M. This contraction results in a growth score of 0/100.

Leverage

Vaso Corp has a moderate D/E ratio of 2.00. This balance of debt and equity financing earns a leverage score of 61/100.

Liquidity

Vaso Corp's current ratio of 1.59 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 27/100, which could limit financial flexibility.

Returns

Vaso Corp generates a 5.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 23/100. This is up from 3.4% the prior year.

Piotroski F-Score Neutral

5/9

Vaso Corp passes 5 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

5.91x

For every $1 of reported earnings, Vaso Corp generates $5.91 in operating cash flow ($9.3M OCF vs $1.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

-115.6x

Vaso Corp earns $-115.6 in operating income for every $1 of interest expense (-$2.9M vs $25K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$42.5M

YoY-51.1%

5Y CAGR-9.5%

10Y CAGR-2.9%

Vaso Corp generated $42.5M in revenue in fiscal year 2025. This represents a decrease of 51.1% from the prior year.

EBITDA

-$2.0M

YoY-283.3%

Vaso Corp's EBITDA was -$2.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 283.3% from the prior year.

Net Income

$1.6M

YoY+65.0%

5Y CAGR+34.4%

10Y CAGR-8.5%

Vaso Corp reported $1.6M in net income in fiscal year 2025. This represents an increase of 65.0% from the prior year.

EPS (Diluted)

$0.01

YoY+0.0%

10Y CAGR-6.7%

Vaso Corp earned $0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$35.0M

YoY+33.4%

5Y CAGR+38.7%

10Y CAGR+32.1%

Vaso Corp held $35.0M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

176M

YoY+0.1%

5Y CAGR+0.1%

10Y CAGR+1.1%

Vaso Corp had 176M shares outstanding in fiscal year 2025. This represents an increase of 0.1% from the prior year.

Margins & Returns

Gross Margin

41.0%

YoY-18.9pp

5Y CAGR-14.2pp

10Y CAGR-20.9pp

Vaso Corp's gross margin was 41.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 18.9 percentage points from the prior year.

Operating Margin

-6.8%

YoY-7.1pp

5Y CAGR-7.9pp

10Y CAGR-13.7pp

Vaso Corp's operating margin was -6.8% in fiscal year 2025, reflecting core business profitability. This is down 7.1 percentage points from the prior year.

Net Margin

3.7%

YoY+2.6pp

5Y CAGR+3.2pp

10Y CAGR-3.0pp

Vaso Corp's net profit margin was 3.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.6 percentage points from the prior year.

Return on Equity

5.3%

YoY+1.9pp

5Y CAGR-1.7pp

10Y CAGR-27.2pp

Vaso Corp's ROE was 5.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.9 percentage points from the prior year.

Capital Allocation

R&D Spending

$728K

YoY-14.5%

5Y CAGR-0.5%

10Y CAGR+3.5%

Vaso Corp invested $728K in research and development in fiscal year 2025. This represents a decrease of 14.5% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

VASO Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$42.5M-51.1%	$86.8M+7.1%	$81.0M+2.2%	$79.3M+4.9%	$75.6M+8.2%	$69.8M
Cost of Revenue	$25.0M-27.9%	$34.7M+14.1%	$30.4M-3.5%	$31.5M-2.8%	$32.4M+3.7%	$31.3M
Gross Profit	$17.4M-66.5%	$52.0M+2.9%	$50.6M+5.6%	$47.9M+11.1%	$43.1M+11.8%	$38.6M
R&D Expenses	$728K-14.5%	$851K+12.7%	$755K+24.8%	$605K-64.8%	$1.7M+131.0%	$745K
SG&A Expenses	$52.2M+6.6%	$49.0M+8.7%	$45.1M+10.4%	$40.8M+5.8%	$38.6M+4.2%	$37.1M
Operating Income	-$2.9M-1114.4%	$285K-93.2%	$4.2M-35.0%	$6.5M+128.9%	$2.8M+265.2%	$772K
Interest Expense	$25K+525.0%	$4K-92.0%	$50K+13.6%	$44K-85.9%	$312K-55.5%	$701K
Income Tax	-$2.9M-981.9%	$326K+226.0%	$100K+102.1%	-$4.7M-3241.1%	$151K+15000.0%	$1K
Net Income	$1.6M+65.0%	$951K-80.2%	$4.8M-57.5%	$11.3M+85.1%	$6.1M+1603.9%	$358K
EPS (Diluted)	$0.010.0%	$0.01-66.7%	$0.03-50.0%	$0.06	N/A	$0.00

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$22.7M+13.5%	$20.0M+2.5%	$19.5M-28.0%	$27.0M+30.2%	$20.8M+2.7%	$20.2M+7.9%	$18.7M-15.7%	$22.2M
Cost of Revenue	$8.8M+7.4%	$8.2M+0.7%	$8.1M-17.4%	$9.8M+8.8%	$9.0M+11.6%	$8.1M+3.3%	$7.8M-1.3%	$7.9M
Gross Profit	$13.9M+17.8%	$11.8M+3.9%	$11.4M-34.1%	$17.2M+46.5%	$11.8M-3.3%	$12.2M+11.3%	$10.9M-23.6%	$14.3M
R&D Expenses	$146K-12.6%	$167K-6.2%	$178K-32.6%	$264K+38.2%	$191K-6.8%	$205K+7.3%	$191K+11.0%	$172K
SG&A Expenses	$12.2M+1.3%	$12.1M-2.8%	$12.4M-15.5%	$14.7M+28.6%	$11.4M+5.2%	$10.8M-10.2%	$12.1M-2.6%	$12.4M
Operating Income	$1.5M+465.3%	-$421K+65.4%	-$1.2M-156.7%	$2.1M+254.3%	-$1.4M-239.9%	$996K+167.8%	-$1.5M-221.4%	$1.2M
Interest Expense	N/A	N/A	N/A	N/A	N/A	$1K-66.7%	$3K0.0%	$3K
Income Tax	$35K-12.5%	$40K0.0%	$40K-76.7%	$172K+473.3%	$30K-73.2%	$112K+833.3%	$12K-81.5%	$65K
Net Income	$1.7M+968.5%	-$197K+81.7%	-$1.1M-150.0%	$2.1M+282.0%	-$1.2M-202.3%	$1.2M+198.5%	-$1.2M-208.5%	$1.1M
EPS (Diluted)	$0.01	$0.00+100.0%	$-0.01	N/A	$-0.01-200.0%	$0.01+200.0%	$-0.01	N/A

VASO Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$88.3M+6.5%	$82.9M+9.5%	$75.8M+5.7%	$71.6M+36.8%	$52.4M+3.9%	$50.4M
Current Assets	$58.6M+14.4%	$51.2M+13.5%	$45.1M+10.0%	$41.0M+47.4%	$27.8M+24.9%	$22.3M
Cash & Equivalents	$35.0M+33.4%	$26.3M+131.6%	$11.3M-4.1%	$11.8M+96.2%	$6.0M-11.6%	$6.8M
Inventory	$833K-8.6%	$911K-38.0%	$1.5M-0.2%	$1.5M+28.4%	$1.1M-17.1%	$1.4M
Accounts Receivable	$850K+142.9%	$350K	N/A	$21.5M+1.2%	$21.2M+51.8%	$14.0M
Goodwill	$11.0M-29.5%	$15.6M-0.2%	$15.6M-0.2%	$15.6M-0.7%	$15.7M0.0%	$15.7M
Total Liabilities	$58.9M+6.7%	$55.2M+12.9%	$48.9M-1.3%	$49.6M+20.1%	$41.3M-8.9%	$45.3M
Current Liabilities	$36.8M+6.1%	$34.7M+15.6%	$30.0M-4.7%	$31.5M+1.6%	$31.0M-2.2%	$31.7M
Long-Term Debt	N/A	N/A	N/A	$15K-34.8%	$23K-99.6%	$5.8M
Total Equity	$29.4M+6.2%	$27.7M+3.2%	$26.8M+21.6%	$22.1M+99.1%	$11.1M+117.9%	$5.1M
Retained Earnings	-$32.5M+4.6%	-$34.1M+2.7%	-$35.0M+12.1%	-$39.8M+21.7%	-$50.9M+10.7%	-$57.0M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$84.5M+2.3%	$82.6M+6.0%	$77.9M-6.1%	$82.9M+12.2%	$73.9M+2.6%	$72.1M+3.8%	$69.4M-8.3%	$75.8M
Current Assets	$51.9M+3.9%	$50.0M+8.7%	$46.0M-10.2%	$51.2M+19.1%	$43.0M+5.1%	$40.9M+4.8%	$39.0M-13.5%	$45.1M
Cash & Equivalents	$34.9M+7.1%	$32.6M+28.6%	$25.3M-3.7%	$26.3M-2.1%	$26.8M+4.6%	$25.7M+31.3%	$19.5M+72.2%	$11.3M
Inventory	$893K-4.9%	$939K-2.7%	$965K+5.9%	$911K-21.1%	$1.2M-5.2%	$1.2M-22.2%	$1.6M+6.5%	$1.5M
Accounts Receivable	N/A	N/A	N/A	$350K	N/A	N/A	N/A	N/A
Goodwill	$15.6M+0.1%	$15.6M+0.1%	$15.6M0.0%	$15.6M-0.3%	$15.6M+0.3%	$15.6M0.0%	$15.6M-0.2%	$15.6M
Total Liabilities	$56.2M+0.3%	$56.1M+9.4%	$51.3M-7.2%	$55.2M+14.4%	$48.3M+6.5%	$45.3M+3.4%	$43.9M-10.3%	$48.9M
Current Liabilities	$31.6M-4.3%	$33.0M+9.2%	$30.2M-12.9%	$34.7M+15.1%	$30.2M+12.4%	$26.8M-1.6%	$27.3M-9.2%	$30.0M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$28.2M+6.5%	$26.5M-0.6%	$26.6M-3.8%	$27.7M+8.0%	$25.7M-4.0%	$26.7M+4.5%	$25.6M-4.7%	$26.8M
Retained Earnings	-$33.6M+4.8%	-$35.4M-0.6%	-$35.2M-3.2%	-$34.1M+5.9%	-$36.2M-3.4%	-$35.0M+3.2%	-$36.2M-3.3%	-$35.0M

VASO Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$9.3M+182.6%	$3.3M-38.0%	$5.3M-63.3%	$14.4M+84.5%	$7.8M+31.7%	$5.9M
Capital Expenditures	N/A	N/A	N/A	$566K+36.4%	$415K-58.5%	$1.0M
Free Cash Flow	N/A	N/A	N/A	$13.8M+87.2%	$7.4M+50.0%	$4.9M
Investing Cash Flow	-$725K-106.2%	$11.7M+307.4%	-$5.7M+32.8%	-$8.4M-3137.3%	-$260K+54.8%	-$575K
Financing Cash Flow	$248K+378.7%	-$89K+33.6%	-$134K+41.7%	-$230K+97.2%	-$8.3M-1406.1%	-$553K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$2.8M-59.0%	$6.8M+1300.5%	-$566K-54.2%	-$367K-119.0%	$1.9M-30.8%	$2.8M+360.6%	-$1.1M+31.6%	-$1.6M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$225K+144.6%	-$504K-38.8%	-$363K-62.8%	-$223K+66.9%	-$673K-119.3%	$3.5M-61.9%	$9.1M+386.6%	$1.9M
Financing Cash Flow	-$690K-171.7%	$963K+3666.7%	-$27K-22.7%	-$22K+21.4%	-$28K+82.5%	-$160K-232.2%	$121K+548.1%	-$27K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

VASO Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	41.0%-18.9pp	60.0%-2.4pp	62.4%+2.0pp	60.4%+3.3pp	57.1%+1.8pp	55.2%
Operating Margin	-6.8%-7.1pp	0.3%-4.9pp	5.2%-3.0pp	8.1%+4.4pp	3.7%+2.6pp	1.1%
Net Margin	3.7%+2.6pp	1.1%-4.8pp	5.9%-8.3pp	14.2%+6.2pp	8.1%+7.6pp	0.5%
Return on Equity	5.3%+1.9pp	3.4%-14.5pp	17.9%-33.3pp	51.2%-3.9pp	55.0%+48.0pp	7.0%
Return on Assets	1.8%+0.6pp	1.1%-5.2pp	6.3%-9.4pp	15.8%+4.1pp	11.7%+10.9pp	0.7%
Current Ratio	1.59+0.1	1.47-0.0	1.50+0.2	1.30+0.4	0.90+0.2	0.70
Debt-to-Equity	2.000.0	1.99+0.2	1.82+1.8	0.000.0	0.00-1.1	1.14
FCF Margin	N/A	N/A	N/A	17.5%+7.7pp	9.8%+2.7pp	7.1%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	61.3%+2.2pp	59.1%+0.7pp	58.4%-5.4pp	63.7%+7.1pp	56.6%-3.5pp	60.1%+1.8pp	58.3%-6.1pp	64.3%
Operating Margin	6.8%+8.9pp	-2.1%+4.2pp	-6.3%-14.2pp	8.0%+14.7pp	-6.7%-11.6pp	4.9%+12.8pp	-7.8%-13.3pp	5.4%
Net Margin	7.5%+8.5pp	-1.0%+4.5pp	-5.5%-13.5pp	8.0%+13.6pp	-5.7%-11.4pp	5.7%+12.0pp	-6.3%-11.1pp	4.9%
Return on Equity	6.1%+6.8pp	-0.7%+3.3pp	-4.0%-11.8pp	7.8%+12.4pp	-4.6%-8.9pp	4.3%+8.9pp	-4.6%-8.6pp	4.0%
Return on Assets	2.0%+2.3pp	-0.2%+1.1pp	-1.4%-4.0pp	2.6%+4.2pp	-1.6%-3.2pp	1.6%+3.3pp	-1.7%-3.1pp	1.4%
Current Ratio	1.64+0.1	1.510.0	1.52+0.0	1.47+0.0	1.43-0.1	1.52+0.1	1.43-0.1	1.50
Debt-to-Equity	1.99-0.1	2.12+0.2	1.92-0.1	1.99+0.1	1.88+0.2	1.70-0.0	1.72-0.1	1.82
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Veri Medtech Holdings VRHI

$19.7M

Reliq Helth Tech RQHTF

$34.1M

Renalytix Plc RNLXY

$327.8M

Pharma-Bio Serv Inc PBSV

$11.7M

Frequently Asked Questions

What is Vaso Corp's annual revenue?

Vaso Corp (VASO) reported $42.5M in total revenue for fiscal year 2025. This represents a -51.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Vaso Corp's revenue growing?

Vaso Corp (VASO) revenue declined by 51.1% year-over-year, from $86.8M to $42.5M in fiscal year 2025.

Is Vaso Corp profitable?

Yes, Vaso Corp (VASO) reported a net income of $1.6M in fiscal year 2025, with a net profit margin of 3.7%.

What is Vaso Corp's EBITDA?

Vaso Corp (VASO) had EBITDA of -$2.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Vaso Corp's gross margin?

Vaso Corp (VASO) had a gross margin of 41.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Vaso Corp's operating margin?

Vaso Corp (VASO) had an operating margin of -6.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Vaso Corp's net profit margin?

Vaso Corp (VASO) had a net profit margin of 3.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Vaso Corp's return on equity (ROE)?

Vaso Corp (VASO) has a return on equity of 5.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Vaso Corp's operating cash flow?

Vaso Corp (VASO) generated $9.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Vaso Corp's total assets?

Vaso Corp (VASO) had $88.3M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Vaso Corp spend on research and development?

Vaso Corp (VASO) invested $728K in research and development during fiscal year 2025.

How many shares does Vaso Corp have outstanding?

Vaso Corp (VASO) had 176M shares outstanding as of fiscal year 2025.

What is Vaso Corp's current ratio?

Vaso Corp (VASO) had a current ratio of 1.59 as of fiscal year 2025, which is generally considered healthy.

What is Vaso Corp's debt-to-equity ratio?

Vaso Corp (VASO) had a debt-to-equity ratio of 2.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Vaso Corp's return on assets (ROA)?

Vaso Corp (VASO) had a return on assets of 1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Vaso Corp's Piotroski F-Score?

Vaso Corp (VASO) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Vaso Corp's earnings high quality?

Vaso Corp (VASO) has an earnings quality ratio of 5.91x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Vaso Corp cover its interest payments?

Vaso Corp (VASO) has an interest coverage ratio of -115.6x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Vaso Corp?

Vaso Corp (VASO) scores 24 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.